糖尿病视网膜病变与痴呆的关联超越糖尿病严重程度
该回顾性队列研究基于成人思维变化(ACT)研究,纳入536例2型糖尿病患者,探讨控制糖尿病严重程度指标后糖尿病视网膜病变(DR)与痴呆及阿尔茨海默病(AD)的关联是否仍显著。结果显示DR病程>5年与痴呆(HR 1.81)及AD(HR 1.80)的显著关联在调整微白蛋白尿、长期血糖及肾功能后仍存在。结论认为DR本身可能是痴呆风险的重要生物标志物。
要点
- 在2型糖尿病患者中,DR病程>5年与痴呆风险显著相关(HR 1.81,95%CI 1.23-2.65)。
- DR病程>5年与AD风险显著相关(HR 1.80,95%CI 1.15-2.82)。
- 调整微白蛋白尿、长期血糖及肾功能后,上述关联仍显著。
核心结论
- 在2型糖尿病患者中,DR本身似乎是痴呆风险的重要生物标志物,其作用独立于血糖和肾脏并发症。
研究设计与样本
- 回顾性队列研究,数据来自成人思维变化(ACT)前瞻性队列研究,纳入536例入组时或随访期间患2型糖尿病的参与者,随访至2018年9月,共3516人年。
主要发现
- DR病程>5年与痴呆的关联:HR 1.81(95%CI 1.23, 2.65)。
- DR病程>5年与AD的关联:HR 1.80(95%CI 1.15, 2.82)。
- 调整微白蛋白尿、长期血糖及肾功能估计后,DR病程>5年与痴呆的关联为HR 1.69(95%CI 1.14, 2.50),与AD的关联为HR 1.73(95%CI 1.10, 2.74)。
关键数值与推荐
- 糖尿病定义为1年内≥2次糖尿病药物配药记录。
- DR诊断基于国际疾病分类第九版和第十版编码。
- 微白蛋白尿、长期血糖及肾功能估计来自纵向实验室记录,作为糖尿病严重程度指标。
- AD和痴呆由专家共识会议依据研究标准诊断。
- 纳入标准:入组时或随访期间患2型糖尿病;基线中位年龄75岁(四分位距71-80),54%为女性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate whether associations between diabetic retinopathy (DR) and dementia and Alzheimer's disease (AD) remain significant after controlling for several measures of diabetes severity. DESIGN: Retrospective cohort study. METHODS: Adult Changes in Thought (ACT) is a prospective cohort study of adults aged ≥65 years, randomly selected and recruited from the membership rolls of Kaiser Permanente Washington, who are dementia free at enrollment and followed biennially until incident dementia. The ACT participants were included in this study if they had type 2 diabetes mellitus at enrollment or developed it during follow-up, and data were collected through September, 2018 (3516 person-years of follow-up). Diabetes was defined by ≥ 2 diabetes medication fills in 1 year. Diagnosis of DR was based on International Classification of Diseases Ninth and Tenth Revision codes. Estimates of microalbuminuria, long-term glycemia, and renal function from longitudinal laboratory records were used as indicators of diabetes severity. Alzheimer's disease and dementia were diagnosed using research criteria at expert consensus meetings. RESULTS: A total of 536 participants (median baseline age 75 [interquartile range 71-80], 54% women) met inclusion criteria. Significant associations between DR >5 years duration with dementia (hazard ratio 1.81 [95% CI 1.23, 2.65]) and AD (1.80 [1.15, 2.82]) were not altered by adjustment for estimates of microalbuminuria, long-term glycemia, and renal function (dementia: 1.69 [1.14, 2.50]; AD: 1.73 [1.10, 2.74]). CONCLUSIONS: Among people with type 2 diabetes, DR itself appears to be an important biomarker of dementia risk in addition to glycemia and renal complications.
引用
- Lee CS, Krakauer C, Su YR, et al. Diabetic Retinopathy and Dementia Association, Beyond Diabetes Severity. Am J Ophthalmol. 2022. PMID: 36513155. doi:10.1016/j.ajo.2022.12.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。